Noveta Health, powered by Southern Scripts, is excited to offer our clients a free health spend analysis on their pharmacy benefit management program. Together, we are bringing more clarity and savings to the pharmacy benefit space then has ever been seen before.
How Do We Find Savings?
Our trademarked Variable Copay program addresses the number one driver of skyrocketing prescription costs, high-cost brands and specialty medications. This program has eclipsed our competition by capturing the full value of pharmaceutical manufacturer coupons and compared it with acquisition costs pricing, in turn providing our clients an average discount rate of 30% on over 2,000 high-cost brand and specialty medications.
(and after Member paid)
| Sovaldi | $4,200 | Humira | $585 |
| Harvoni | $3,653 | Copaxone | $580 |
| Stelara | $2,591 | Enbrel | $575 |
| Orkambi | $1,200 | Cimzia | $550 |
| Simponi | $741 | Xeljanz | $538 |
A mattress manufacturer is being “up-charged” nearly $1M in “spread” or drug markup pricing. That is pure profit for the PBM or other entities who are receiving compensation for your business.
Savings #1 – That $1M goes away immediately by contracting with
Southern Scripts and my 100% passthrough pricing contracts.
Savings #2 – Through our trademarked Variable Copay program for
high cost brand ad specialty drugs, where we maximize the value of
pharmaceutical manufacturer coupons for the members AND the
employer, we delivered additional savings of over $500,000 (conservative
estimate). We provide this program on over 2,000 medications and
growing.
Savings #3 – We delivered nearly a quarter million dollars in
conservative savings by deploying smart clinical management
strategies, for instance dispensing a generic instead of the more
expensive brand medication.
We found that they should be receiving between $510,000 – $690,000 in rebates
– we passed these back to them 100%.
All in, including netting out our administrative fee which we contractually warrant is our sole source of revenue, we were able to
save this manufacturer nearly $1.5M on your annual drug spend – just over $16 per prescription across all prescriptions.
| Drug | # of Rx | Plan Total Paid | Net Paid Per Rx | Net Paid Per Rx | Net Paid Per Rx |
|---|---|---|---|---|---|
| Revlimid | 8 | $103,555.36 | $12,944.42 | $2,015.87 | $16,126.96 |
| Humira Pen | 33 | $151,300.05 | $4,584.85 | $1,151.84 | $38,010.72 |
| Lantus | 20 | $5,189.00 | $259.45 | $149.94 | $2,998.80 |
| Lantus SoloStar | 20 | $15,417.40 | $770.87 | $290.74 | $5,814.80 |
| Janumet | 34 | $14,009.02 | $412.03 | $114.20 | $3,882.80 |
| Victoza | 31 | $23,964.86 | $773.06 | $129.31 | $4,008.61 |
| Invokana | 65 | $28,713.75 | $441.75 | $380.07 | $24,704.55 |
| Trokendi XR | 4 | $1,859.88 | $464.97 | $160.72 | $642.88 |
| Xarelto | 36 | $14,469.84 | $401.94 | $216.49 | $7,793.64 |
| Farxiga | 23 | $10,253.17 | $401.94 | $205.46 | $4,725.58 |
| Januvia | 20 | $7,893.80 | $394.69 | $96.86 | $1,937.20 |
| Levemir FlexTouch | 20 | $8,406.60 | $420,33 | $69.68 | $1,393.60 |
| HumaLOG | 15 | $12,779.55 | $851.97 | $189.52 | $2,842.80 |
| HumaLOG KwikPen | 20 | $10,977.40 | $548.87 | $143.34 | $2,866.80 |
| NovoLOG | 17 | $9,695.10 | $570.30 | $110.82 | $1,883.94 |
| Total | 366 | $418,484.78 | $24,285.29 | $24,285.29 | $119,633.68 |